Clinical cases of extrapulmonary manifestations in patients with coronavirus disease (COVID-19)

IF 0.1 Q4 PATHOLOGY
O. Riabokon, К. А. Pak, О. О. Furyk, V. V. Cherkaskyi
{"title":"Clinical cases of extrapulmonary manifestations in patients with coronavirus disease (COVID-19)","authors":"O. Riabokon, К. А. Pak, О. О. Furyk, V. V. Cherkaskyi","doi":"10.14739/2310-1237.2022.2.257403","DOIUrl":null,"url":null,"abstract":"The aim of the work – to provide variants of extrapulmonary manifestations of coronavirus disease (COVID-19) based on the analysis of the relevant course of the disease in adults.\nResults. The paper presents two clinical cases of coronavirus disease (COVID-19) with the manifestation of extrapulmonary symptoms, which required some individualization of therapy.\nThe first clinical observation showed that in a 56-year-old patient with moderate COVID-19, the development of oxygen dependence on the 8th day of the disease was combined with the manifestation of extrapulmonary symptoms in the form of cutaneous manifestations. Individualization of glucocorticosteroid therapy and endothelioprotective therapy has been shown to be effective in regressing both oxygen dependence and cutaneous vasculitis.\nThe second clinical observation showed that in a 35-year-old patient, moderate COVID-19 without oxygen dependence was accompanied by the development of extrapulmonary manifestations, namely short-lasting diarrheal syndrome, which manifested in the onset of the disease and of the development of orchiepididymitis on the 9th day of illness, which required the appointment of anti-inflammatory therapy.\nConclusions. The abovementioned clinical observations of COVID-19 cases show relatively rare cases of SARS-CoV-2- associated extrapulmonary manifestations in patients with moderate disease, but their development necessitated individualization of treatment.\n ","PeriodicalId":41645,"journal":{"name":"Pathologia","volume":"36 1","pages":""},"PeriodicalIF":0.1000,"publicationDate":"2022-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pathologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14739/2310-1237.2022.2.257403","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The aim of the work – to provide variants of extrapulmonary manifestations of coronavirus disease (COVID-19) based on the analysis of the relevant course of the disease in adults. Results. The paper presents two clinical cases of coronavirus disease (COVID-19) with the manifestation of extrapulmonary symptoms, which required some individualization of therapy. The first clinical observation showed that in a 56-year-old patient with moderate COVID-19, the development of oxygen dependence on the 8th day of the disease was combined with the manifestation of extrapulmonary symptoms in the form of cutaneous manifestations. Individualization of glucocorticosteroid therapy and endothelioprotective therapy has been shown to be effective in regressing both oxygen dependence and cutaneous vasculitis. The second clinical observation showed that in a 35-year-old patient, moderate COVID-19 without oxygen dependence was accompanied by the development of extrapulmonary manifestations, namely short-lasting diarrheal syndrome, which manifested in the onset of the disease and of the development of orchiepididymitis on the 9th day of illness, which required the appointment of anti-inflammatory therapy. Conclusions. The abovementioned clinical observations of COVID-19 cases show relatively rare cases of SARS-CoV-2- associated extrapulmonary manifestations in patients with moderate disease, but their development necessitated individualization of treatment.  
新型冠状病毒病(COVID-19)患者肺外表现临床分析
本研究的目的是在分析成人冠状病毒病(COVID-19)相关病程的基础上,提供其肺外表现的变异。本文报告了2例以肺外症状为表现的新型冠状病毒病(COVID-19)临床病例,需要个体化治疗。首次临床观察发现,56岁中度新冠肺炎患者,发病第8天出现氧依赖,并以皮肤表现形式出现肺外症状。个体化糖皮质激素治疗和内皮保护治疗已被证明对氧依赖和皮肤血管炎都是有效的。第二次临床观察显示,35岁患者中,无氧依赖的中度COVID-19伴肺外表现,即短时间腹泻综合征,表现为发病,发病第9天发展为睾丸附睾炎,需要预约抗炎治疗。上述COVID-19病例的临床观察显示,在中度疾病患者中出现SARS-CoV-2相关肺外表现的病例相对较少,但其发展需要个体化治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pathologia
Pathologia PATHOLOGY-
自引率
0.00%
发文量
13
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书